StonvexLoading…
StonvexStonvexStonvexCore line items from OKTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-30 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 |
|---|---|---|---|---|
Revenue | $765.00M | $2.92B | $2.16B | $1.42B |
Operating Income | $56.00M | $149.00M | $103.00M | $80.00M |
Net Income | $74.00M | $235.00M | $172.00M | $67.00M |
EPS (Diluted) | $0.42 | $1.31 | $0.96 | $0.72 |
Total Assets | $9.35B | $9.71B | $9.23B | $9.55B |
Total Liabilities | $2.45B | $2.71B | $2.34B | $2.80B |
Cash & Equivalents | $762.00M | $858.00M | $645.00M | $876.00M |
Free Cash Flow OCF − CapEx | $276.00M | $875.00M | $619.00M | $405.00M |
Shares Outstanding | 177.70M | 179.29M | 179.39M | 181.36M |